Anti-cancer treatment is now under way with a highly sophisticated and versatile linear accelerator that’s newly installed at the JGH.
A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.
A major donation has led to creation of a JGH-based consortium to improve the outcomes of lung cancer patients through customized treatments.
The Segal Cancer Centre at the JGH has responded to COVID-19 with compassion and innovation by enabling patients can consult with oncologists by video as an alternative to face-to-face meetings.
Dr. Gerald Batist, Director of the Segal Cancer Centre and Deputy Director of the Lady Davis Institute at the JGH, has received the 2019 Award for Exceptional Leadership in Cancer Research from the Canadian Cancer Research Alliance.
In 1981, Hope & Cope was launched under the auspices of the JGH Auxiliary to use specially trained volunteers (many of whom were cancer survivors) to support and counsel cancer patients and their families.